WeightWatchers Moves Into the Ozempic Market With Telehealth Deal
WW International Inc., known as WeightWatchers, is buying digital health company Sequence, marking the diet company’s move into the hot market for diabetes and obesity drugs including Ozempic and Wegovy. Sequence is a subscription service that offers telehealth visits with doctors who can prescribe the drugs.
Read More from the Global Wellness News ™